{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Bizelesin",
  "nciThesaurus": {
    "casRegistry": "129655-21-6",
    "chebiId": "",
    "chemicalFormula": "C43H36Cl2N8O5",
    "definition": "A synthetic cyclopropylpyrroloindole antineoplastic antibiotic.  Bizelesin binds to the minor groove of DNA and induces interstrand cross-linking of DNA, thereby inhibiting DNA replication and RNA synthesis.  Bizelesin also enhances p53 and p21 induction and triggers G2/M cell-cycle arrest, resulting in cell senescence without apoptosis.",
    "fdaUniiCode": "L0O9OBI87E",
    "identifier": "C1472",
    "preferredName": "Bizelesin",
    "semanticType": "Organic Chemical",
    "subclassOf": [],
    "synonyms": [
      "BIZELESIN",
      "Benzo(1,2-b:4,3-b')dipyrrol-4-ol, 6,6'-(carbonylbis(imino-1H-indole-5,2-diylcarbonyl))bis(8-(chloromethyl)-3,6,7,8-tetrahydro-1-methyl-, (S-(R*,R*)))-",
      "Benzo[1,2-b:4,3-b']dipyrrol-4-ol, 6, 6'-[carbonylbis(imino- 1H-indole-5, 2-diylcarbonyl)]bis[8-(chloromethyl)-3,6,7,8-tetrahydro-1-methyl-, (S-(R*,R*))]",
      "Bizelesin",
      "U-77779",
      "bizelesin"
    ]
  }
}